Teva Pharmaceutical Shares Drop Following Departure of R&D Head

Shares of Teva Pharmaceutical (TEVA) declined by nearly 7% on Thursday following the announcement that Eric Hughes, the head of Research and Development, is leaving the company. The leadership change comes at a critical juncture for the pharmaceutical firm as it attempts to pivot its business model. The departure occurs while Teva is actively shifting its strategic focus toward expanding its portfolio of innovative medicines. This transition marks a significant move away from its traditional reliance on generic drugs, making the stability and direction of its R&D department vital to investor confidence.

By https://seekingalpha.com/user/52867120/bio · Seeking Alpha ·

Teva Pharmaceutical Shares Drop Following Departure of R&D Head

Tickers: $TEVA

Topics: executive resignation R&D strategy stock price movement

Read the full article at Seeking Alpha

More World news